CVE-2013-0430

N/A

Descripcion

Unspecified vulnerability in the Java Runtime Environment (JRE) component in Oracle Java SE 7 through Update 11 and 6 through Update 38, allows local users to affect confidentiality, integrity, and availability via unknown vectors related to the installation process of the client.

Detalles CVE

Puntuacion CVSS v3.1N/A

Publicado2/2/2013

Ultima modificacion4/11/2025

Fuentenvd

Avistamientos honeypot0

Productos afectados

oracle:jdkoracle:jresun:jdksun:jre

Referencias

http://marc.info/?l=bugtraq&m=136733161405818&w=2(secalert_us@oracle.com)

http://rhn.redhat.com/errata/RHSA-2013-0236.html(secalert_us@oracle.com)

http://rhn.redhat.com/errata/RHSA-2013-0237.html(secalert_us@oracle.com)

http://www.kb.cert.org/vuls/id/858729(secalert_us@oracle.com)

http://www.oracle.com/technetwork/topics/security/javacpufeb2013-1841061.html(secalert_us@oracle.com)

http://www.securityfocus.com/bid/57722(secalert_us@oracle.com)

http://www.us-cert.gov/cas/techalerts/TA13-032A.html(secalert_us@oracle.com)

https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A16600(secalert_us@oracle.com)

http://marc.info/?l=bugtraq&m=136733161405818&w=2(af854a3a-2127-422b-91ae-364da2661108)

http://rhn.redhat.com/errata/RHSA-2013-0236.html(af854a3a-2127-422b-91ae-364da2661108)

http://rhn.redhat.com/errata/RHSA-2013-0237.html(af854a3a-2127-422b-91ae-364da2661108)

http://www.kb.cert.org/vuls/id/858729(af854a3a-2127-422b-91ae-364da2661108)

http://www.oracle.com/technetwork/topics/security/javacpufeb2013-1841061.html(af854a3a-2127-422b-91ae-364da2661108)

http://www.securityfocus.com/bid/57722(af854a3a-2127-422b-91ae-364da2661108)

http://www.us-cert.gov/cas/techalerts/TA13-032A.html(af854a3a-2127-422b-91ae-364da2661108)

https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A16600(af854a3a-2127-422b-91ae-364da2661108)

Correlaciones IOC

Sin correlaciones registradas

This product uses data from the NVD API but is not endorsed or certified by the NVD.